Updating results

Certolizumab pegol for treating moderate to severe plaque psoriasis (TA574)

Evidence-based recommendations on certolizumab pegol (Cimzia) for treating moderate to severe plaque psoriasis in adults

Technology appraisal guidance Published April 2019

Endoscopic ablation for a pilonidal sinus (IPG646)

Evidence-based recommendations on endoscopic ablation for a pilonidal sinus in adults

Interventional procedures guidance Published April 2019

Endoscopic ablation for an anal fistula (IPG645)

Evidence-based recommendations on endoscopic ablation for an anal fistula in adults

Interventional procedures guidance Published April 2019

Ectopic pregnancy and miscarriage: diagnosis and initial management (NG126)

This guideline covers diagnosing and managing ectopic pregnancy and miscarriage in women with complications, such as pain and bleeding, in early pregnancy (that is, up to 13 completed weeks of pregnancy). It aims to improve how early pregnancy loss is diagnosed, and the support women are given, to limit the psychological impact of their loss.

NICE guideline Published April 2019

Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) (TA576)

NICE is unable to make a recommendation about the use in the NHS of bosutinib for untreated chronic myeloid leukaemia because no evidence submission was

Technology appraisal guidance Published April 2019

Offer women a choice of procedure to terminate their pregnancy

All women should be able to access both medical and surgical procedures to terminate their pregnancy, says NICE in draft guidance.

News Published April 2019 Last updated April 2019

Surgical site infections: prevention and treatment (NG125)

This guideline covers preventing and treating surgical site infections in adults, young people and children who are having a surgical procedure involving a cut through the skin. It focuses on methods used before, during and after surgery to minimise the risk of infection.

NICE guideline Published April 2019

Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (TA573)

Evidence-based recommendations on daratumumab (Darzalex) with bortezomib and dexamethasone for previously treated multiple myeloma in adults

Technology appraisal guidance Published April 2019

NICE encourages use of greener asthma inhalers

People with asthma will be helped to choose the inhaler that is best for them, and best for the environment, by a new patient decision aid from NICE

News Published April 2019 Last updated April 2019

Specialist neonatal respiratory care for babies born preterm (NG124)

This guideline covers specific aspects of respiratory support (for example, oxygen supplementation, assisted ventilation, treatment of some respiratory disorders, and aspects of monitoring) for preterm babies in hospital.

NICE guideline Published April 2019

What Works: How NICE has helped spread empiricism into other professions

Dr David Halpern, What Works national adviser, discusses how NICE has inspired evidence-based decision making across the public sector

News Published April 2019 Last updated April 2019

Changing the role of assessment for young people affected by sexual exploitation

Mike Williams, senior evaluator, NSPCC, describes why assessment of children at risk needs to be more adaptive

News Published March 2019 Last updated March 2019

Promising lung cancer treatment approved for Cancer Drugs Fund

A promising new lung cancer treatment will be available on the NHS through the Cancer Drugs Fund, thanks to a new NICE recommendation.

News Published March 2019 Last updated March 2019

Lung cancer: diagnosis and management (NG122)

This guideline covers diagnosing and managing non-small-cell and small-cell lung cancer. It aims to improve outcomes for patients by ensuring that the most effective tests and treatments are used, and that people have access to suitable palliative care and follow-up.

NICE guideline Published March 2019

NICE publishes a summary of its guidance and other safety advice on valproate

NICE has today (28 March) published a summary for healthcare professionals bringing together all its recommendations and other safety advice on the drug valproate.

News Published March 2019 Last updated March 2019

Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)

Evidence-based recommendations on ertugliflozin (Steglatro) as monotherapy or with metformin for treating type 2 diabetes in adults

Technology appraisal guidance Published March 2019

Building on the first 20 years: the NICE Connect project

NICE is embarking on an ambitious multi-year programme that will review the way we produce and present guidance and advice

News Published March 2019 Last updated March 2019

The Debrisoft monofilament debridement pad for use in acute or chronic wounds (MTG17)

Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds

Medical technologies guidance Published March 2014 Last updated March 2019

Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib (TA571)

Evidence-based recommendations on brigatinib (Alunbrig) for treating ALK-positive advanced non-small-cell lung cancer in adults who have already had crizotinib

Technology appraisal guidance Published March 2019

Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal) (TA570)

NICE is unable to make a recommendation about the use in the NHS of pembrolizumab (Keytruda) for treating recurrent or metastatic squamous cell carcinoma of the

Technology appraisal guidance Published March 2019

Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer (TA569)

Evidence-based recommendations on pertuzumab (Perjeta) for adjuvant treatment (with trastuzumab and chemotherapy) of HER2-positive early stage breast cancer

Technology appraisal guidance Published March 2019

NICE celebrates its 20th anniversary

Organisation was founded in April 1999 to improve outcome for health service users

News Published March 2019 Last updated March 2019

Delirium: prevention, diagnosis and management (CG103)

This guideline covers diagnosing and treating delirium in people aged 18 and over in hospital and in long-term residential care or a nursing home. It also covers identifying people at risk of developing delirium in these settings and preventing onset. It aims to improve diagnosis of delirium and reduce hospital stays and complications.

Clinical guideline Published July 2010 Last updated March 2019

Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal) (TA568)

NICE is unable to make a recommendation on abatacept (Orencia) for treating psoriatic arthritis after DMARDs in adults because of no evidence submission from

Technology appraisal guidance Published March 2019

Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (TA567)

Evidence-based recommendations on tisagenlecleucel therapy (Kymriah) for treating relapsed or refractory diffuse large B-cell lymphoma in adults

Technology appraisal guidance Published March 2019

Radially emitting laser fibre treatment of an anal fistula (IPG644)

Evidence-based recommendations on radially emitting laser fibre treatment of an anal fistula in adults

Interventional procedures guidance Published March 2019

Thousands set to benefit from blood pressure treatment under new NICE guidance

NICE has today (28 August 2019) published its updated guideline on the diagnosis and treatment of high blood pressure (hypertension).

News Published March 2019 Last updated March 2019

A new model for clinical decision making in patients with multimorbidity

Multimorbidity needs a new model of treatment, the authors explain why and how

News Published March 2019 Last updated March 2019

890 more children and adults eligible for cochlear implants on the NHS each year

Hundreds more people with severe to profound deafness will be eligible for cochlear implants each year, due to updated NICE guidance

News Published March 2019 Last updated March 2019

Cochlear implants for children and adults with severe to profound deafness (TA566)

Evidence-based recommendations on cochlear implants for children and adults with severe to profound deafness

Technology appraisal guidance Published March 2019

Research that saves lives

Cathy Rodway, Programme Manager at the National Confidential Inquiry into Suicide and Safety in Mental Health (NCISH), tells us why it is important to support the review of self-harm services in local areas

News Published March 2019 Last updated March 2019

Local authorities urged to ensure building developers address air pollution

The updated quality standard highlights that authorities should assess planning applications and consider how the effects of traffic-related air pollution may affect local communities.

News Published February 2019 Last updated February 2019

Dabrafenib with trametinib for treating advanced metastatic BRAF V600E mutation-positive non-small-cell lung cancer (terminated appraisal) (TA564)

NICE is unable to make a recommendation about the use in the NHS of dabrafenib with trametinib for treating advanced metastatic BRAF V600E mutation-positive

Technology appraisal guidance Published February 2019

Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer (TA563)

Evidence-based recommendations on abemaciclib (Verzenios) for treating locally advanced or metastatic, hormone receptor-positive, human epidermal growth factor

Technology appraisal guidance Published February 2019

Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma (TA562)

Evidence-based recommendations on encorafenib (Braftovi) with binimetinib (Mektovi) for treating unresectable or metastatic BRAF V600 mutation-positive melanoma

Technology appraisal guidance Published February 2019

Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia (TA561)

Evidence-based recommendations on venetoclax (Venclyxto) with rituximab for previously treated chronic lymphocytic leukaemia in adults

Technology appraisal guidance Published February 2019

High-intensity focused ultrasound for symptomatic benign thyroid nodules (IPG643)

Evidence-based recommendations on high-intensity focused ultrasound for symptomatic benign thyroid nodules in adults

Interventional procedures guidance Published February 2019

NICE says drug to treat Batten disease cannot be recommended for NHS use because company is unable to address concerns about long-term effectiveness

NICE has published draft guidance which confirms its earlier decision not to recommend cerliponase alfa (also called Brineura and made by Biomarin) for children with Batten disease – a very rare inherited condition affecting between 1 and 6 babies each year in the UK.

News Published February 2019 Last updated February 2019

Shared Learning Awards: Judges reveal 20 shortlisted entries to be displayed at NICE annual conference

More than 60 entries received from organisations across the country which highlight how they put NICE guidance into practice

News Published February 2019 Last updated February 2019

Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal) (TA560)

NICE is unable to make a recommendation about the use in the NHS of bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence

Technology appraisal guidance Published February 2019

Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal (IPG642)

Evidence-based recommendations on Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal

Interventional procedures guidance Published February 2019

Medicines optimisation: Why is it important and where to start

Karen O’Brien, CDAO leading on Greater Manchester Strategy Implementation Plan, Greater Manchester Health & Social Care Partnership (HSCP), discusses medicines optimisation and the resources available on the NICE website

News Published February 2019 Last updated February 2019

NICE draft guidance recommends pertuzumab for new breast cancer indication after improved price offer from company

NICE has published final draft guidance recommending pertuzumab (Perjeta, Roche) for treating early HER2-positive breast cancer in people whose disease has spread to their lymph nodes.

News Published February 2019 Last updated February 2019

NICE provides first scientific advice on patient preference study design

The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided its first piece of advice on the design of a patient preference study.

News Published February 2019 Last updated February 2019

NICE and Public Health England publish new antibiotic prescribing guidance for patients with suspected pneumonia

These two guidelines set out an antimicrobial prescribing strategy that aims to optimise antibiotic use and reduce antibiotic resistance.

News Published February 2019 Last updated February 2019

Helping to support young people after abuse

Angelica experienced abuse aged 12. She shares her story and talks about her role in developing NICE guidance.

News Published February 2019 Last updated February 2019

NICE updates guideline on alcohol education in schools

NICE is updating its guideline on Alcohol interventions in secondary and further education.

News Published February 2019 Last updated February 2019

Cough (acute): antimicrobial prescribing (NG120)

This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.

Antimicrobial prescribing guideline Published February 2019

NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice

NICE and the Canadian Agency for Drugs and Technology in Health (CADTH) have launched a new collaboration to offer parallel scientific advice to the life sciences industry.

News Published February 2019 Last updated February 2019

Antenatal care for uncomplicated pregnancies (CG62)

This guideline covers the care that healthy women and their babies should be offered during pregnancy. It aims to ensure that pregnant women are offered regular check-ups, information and support.

Clinical guideline Published March 2008 Last updated February 2019